semaglutide glp 1 analogue glp-1 GLP-1 analogs, new trend in obesity treatment, become even more effective < Pharma < Article Key Facts GPs Should Know

NAFLD: Non-alcoholic fatty liver disease

[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Leshan RL, Greenwald-Yarnell M, Patterson CM, Gonzalez IE, Myers MG

Participants were randomly divided into two groups: semaglutide 2.4 mg once weekly vs

removed 2,124,209 shares (-89.4%) from their portfolio in Q1 2026, for an estimated $1,940,273,742 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO removed 1,721,029 shares (-13.8%) from their portfolio in Q1 2026, for an estimated $1,572,005,098 FIFTH THIRD BANCORP added 1,497,423 shares (+321.3%) to their portfolio in Q1 2026, for an estimated $1,367,761,142 ASSENAGON ASSET MANAGEMENT S.A